Assignee
HELIXMITH CO LTD
KR·13 granted patents·13 pending applications·1 citations·filing 2014–2023
Top patents by PatentIndex Score
26 records- 0174US2022362338A1Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathyHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 0272US2022296679A1Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathyHELIXMITH CO LTD·Filed 2021·Application pending·0 cites
- 0371US11279769B2Anti-Sialyl Tn chimeric antigen receptorsHELIXMITH CO LTD·Filed 2016·Granted Mar 22, 2022·1 cites·25 claims
- 0468US10759841B2Gene therapy for diabetic neuropathy using an HGF isoformHELIXMITH CO LTD·Filed 2019·Granted Sep 1, 2020·0 cites·2 claims
- 0568US2019381138A1Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathyHELIXMITH CO LTD·Filed 2019·Application pending·0 cites
- 0668US2026015628A1Aav vector optimized for intrathecal administration into which hepatocyte growth factor gene is introducedHELIXMITH CO LTD·Filed 2023·Application pending·0 cites
- 0767US2023218704A1Crude drug composition for preventing or treating respiratory diseasesHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 0866US2020354420A1Gene therapy for diabetic neuropathy using an hgf isoformHELIXMITH CO LTD·Filed 2020·Application pending·0 cites
- 0965US11541097B2Crude drug composition for preventing or treating respiratory diseasesHELIXMITH CO LTD·Filed 2019·Granted Jan 3, 2023·0 cites·4 claims
- 1064USRE48404EHybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factorHELIXMITH CO LTD·Filed 2017·Granted Jan 26, 2021·0 cites·21 claims
- 1163US2024002462A1Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructsHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 1257US11554179B2Lyophilized pharmaceutical compositions for naked DNA gene therapyHELIXMITH CO LTD·Filed 2019·Granted Jan 17, 2023·0 cites·18 claims
- 1357US2020024323A1Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructsHELIXMITH CO LTD·Filed 2019·Application pending·0 cites
- 1457US2022133827A1Herbal composition for preventing or treating benign prostatic hyperplasia diseaseHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 1556US2022023370A1Composition for preventing or treating metabolic bone diseases or menopausal symptomsHELIXMITH CO LTD·Filed 2019·Application pending·0 cites
- 1655US11975039B2Herbal composition for treatment of attention deficit hyperactivity disorderHELIXMITH CO LTD·Filed 2019·Granted May 7, 2024·0 cites·9 claims
- 1755US11634728B2Adeno-associated virus (AAV) vector having hybrid HGF gene introduced theretoHELIXMITH CO LTD·Filed 2018·Granted Apr 25, 2023·0 cites·3 claims
- 1852US11559555B2Crude drug composition for preventing or treating respiratory diseasesHELIXMITH CO LTD·Filed 2019·Granted Jan 24, 2023·0 cites·4 claims
- 1952US2025205154A1Liquid formulation pharmaceutical composition comprising plasmid dnaHELIXMITH CO LTD·Filed 2022·Application pending·0 cites
- 2049US2022193171A1Pharmaceutical composition comprising mixture extract of coptis rhizome and schizonepeta tenuifolia as active ingredient for prevention or treatment of inflammatory bowel diseaseHELIXMITH CO LTD·Filed 2020·Application pending·0 cites
- 2145US12570719B2Chimeric antigen receptor comprising anti c-met antibody or antigen binding fragment thereof, and use thereofHELIXMITH CO LTD·Filed 2020·Granted Mar 10, 2026·0 cites·16 claims
- 2244US12180287B2Anti-c-Met antibody showing enhanced stability or antigen-binding fragments thereofHELIXMITH CO LTD·Filed 2019·Granted Dec 31, 2024·0 cites·5 claims
- 2344US10639351B2Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factorHELIXMITH CO LTD·Filed 2014·Granted May 5, 2020·0 cites·11 claims
- 2444US2020297790A1Herbal composition for preventing or treating benign prostatic hyperplasia diseaseHELIXMITH CO LTD·Filed 2018·Application pending·0 cites
- 2541US11510999B2Treatment of neuropathy with DNA constructs expressing IGF-1 isoformsHELIXMITH CO LTD·Filed 2019·Granted Nov 29, 2022·0 cites·15 claims
- 2636US11219667B2Method for treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1AHELIXMITH CO LTD·Filed 2015·Granted Jan 11, 2022·0 cites·9 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →